Rating History for Rapt Therapeutics (RAPT) by Leerink Partners
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 1/21/2026 | Thomas Smith | Downgrade | Market Perform (Outperform) |
58.00 (60.00) |
35.10 (58.02) |
65.3% | Details |
 |
|||||||
|
|||||||
|
|||||||
|
|||||||
|
|||||||
